Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts.

Trophoblast research over the past decades has underlined the striking similarities between the proliferative, migratory and invasive properties of placental cells and those of cancer cells. This review recapitulates the numerous key molecules, proto-oncogenes, growth factors, receptors, enzymes, hormones, peptides and tumour-associated antigens (TAAs) expressed by both trophoblastic and cancer cells in an attempt to evaluate the genes and proteins forming molecular circuits and regulating the similar behaviours of these cells. Among the autocrine and paracrine loops that might be involved in the strong proliferative capacity of trophoblastic and cancer cells, epidermal growth factor (EGF)/EGF receptor (EGFR), hepatocyte growth factor (HGF)/HGF receptor (HGFR) (Met) and vascular endothelial growth factor (VEGF)/VEGF receptor (VEGFR) loops may play a predominant role. Similar mechanisms of migration and invasion displayed by trophoblastic and malignant cells comprise alterations in the adhesion molecule phenotype, including the increased expression of alpha1beta1 and alphavbeta3 integrin receptors, whereas another critical molecular event is the down-regulation of the cell adhesion molecule E-cadherin. Among proteases that may play an active role in the invasive capacities of these cells, accumulating evidence suggests that matrix metalloproteinase-9 (MMP-9) expression/activation is a prerequisite. Finally, an overview of molecular circuitries shared by trophoblast and cancer cells reveals that the activation of the phosphatidylinositol 3'-kinase (PI3K)/AKT axis has recently emerged as a central feature of signalling pathways used by these cells to achieve their proliferative, migratory and invasive processes.

[1]  A. H. Diwan,et al.  Expression of Thyrotropin-Releasing Hormone by Human Melanoma and Nevi , 2004, Clinical Cancer Research.

[2]  Dihua Yu,et al.  Early placenta insulin-like growth factor (pro-EPIL) is overexpressed and secreted by c-erbB-2-positive cells with high invasion potential. , 2002, Cancer Research.

[3]  C. Chen,et al.  Expression of granulocyte colony stimulating factor receptor in human colorectal cancer , 2005, Postgraduate Medical Journal.

[4]  Y. Sugisaki,et al.  Expression of p73 and c-Abl proteins in human ovarian carcinomas. , 2003, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[5]  D. Elder,et al.  Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. , 1990, Cancer research.

[6]  D. Drubin,et al.  Functional cooperation between the microtubule and actin cytoskeletons. , 2000, Current opinion in cell biology.

[7]  T. Löning,et al.  Osteopontin is colocalized with the adhesion molecule CEACAM1 in the extravillous trophoblast of the human placenta and enhances invasion of CEACAM1-expressing placental cells. , 2005, The Journal of clinical endocrinology and metabolism.

[8]  B. Tsang,et al.  EGF-induced trophoblast secretion of MMP-9 and TIMP-1 involves activation of both PI3K and MAPK signalling pathways. , 2004, Reproduction.

[9]  M. Post,et al.  Focal Adhesion Kinase Is a Key Mediator of Human Trophoblast Development , 2001, Laboratory Investigation.

[10]  F. Petraglia,et al.  Follistatin-related gene expression, but not follistatin expression, is decreased in human endometrial adenocarcinoma. , 2004, European journal of endocrinology.

[11]  Tak W. Mak,et al.  Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis , 2006, Nature Reviews Cancer.

[12]  J. P. Geisler,et al.  Nuclear and cytoplasmic c‐myc staining in endometrial carcinoma and their relationship to survival , 2004, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[13]  P. Chomez,et al.  Characterization of the GAGE genes that are expressed in various human cancers and in normal testis. , 1999, Cancer research.

[14]  M. Menegaki,et al.  Distribution of somatostatin in pancreatic ductal adenocarcinoma remodels the normal pattern of the protein during foetal pancreatic development: an immunohistochemical analysis , 2005, Clinical and Experimental Medicine.

[15]  P. Bonnier,et al.  Comparison of the prognosis indication of VEGFR-1 and VEGFR-2 and Tie2 receptor expression in breast carcinoma. , 2005, International journal of oncology.

[16]  S. Fisher,et al.  Human cytotrophoblast invasion is up-regulated by epidermal growth factor: evidence that paracrine factors modify this process. , 1994, Developmental biology.

[17]  V. Ilvesmäki,et al.  Insulin-like growth factors (IGFs) and their receptors in adrenal tumors: high IGF-II expression in functional adrenocortical carcinomas. , 1993, The Journal of clinical endocrinology and metabolism.

[18]  H. Hausen,et al.  Loss of Net as Repressor Leads to Constitutive Increased c-fos Transcription in Cervical Cancer Cells* , 2005, Journal of Biological Chemistry.

[19]  Frans,et al.  Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene , 1993, The Journal of cell biology.

[20]  A. Campana,et al.  Paracrine and autocrine regulators of trophoblast invasion--a review. , 2000, Placenta.

[21]  T. Tomita,et al.  Immunohistochemical localization of renin in renal tumors. , 1987, The American journal of pathology.

[22]  S. Fisher,et al.  Regulation of human placental development by oxygen tension. , 1997, Science.

[23]  T. Löning,et al.  Osteopontin Expression in Gestational Trophoblastic Diseases: Correlation With Expression of the Adhesion Molecule, CEACAM1 , 2005, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[24]  T. Hagemann,et al.  The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells. , 2005, Cancer research.

[25]  S. Horvath,et al.  Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Shibuya,et al.  A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. , 1995, Oncogene.

[27]  T. Ueda,et al.  Expression of c-Ets1 Protein in Normal Human Placenta , 2006, Gynecologic and Obstetric Investigation.

[28]  J. Gutterman,et al.  C-sis and C-abl expression in chronic myelogenous leukemia and other hematologic malignancies. , 1986, Blood.

[29]  M. Iruela-Arispe Normal placentation: a tale that requires an epithelial-to-endothelial conversion. , 1997, The Journal of clinical investigation.

[30]  S. Bustin,et al.  The GH–IGF-I axis and breast cancer , 2003, Trends in Endocrinology & Metabolism.

[31]  E. Appella,et al.  Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. , 1990, The EMBO journal.

[32]  N. Ling,et al.  Local production and action of follistatin in human placenta. , 1994, The Journal of clinical endocrinology and metabolism.

[33]  C. Parish,et al.  Evidence that sulphated polysaccharides inhibit tumour metastasis by blocking tumour‐cell‐derived heparanases , 1987, International journal of cancer.

[34]  Caroline,et al.  Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo. , 1992, The Journal of clinical investigation.

[35]  L. Orci,et al.  The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes , 1990, The Journal of cell biology.

[36]  Y. Kodera,et al.  Plasminogen activator inhibitor-1 as a potential marker for the malignancy of colorectal cancer , 2005, British Journal of Cancer.

[37]  M. Malatesta,et al.  Prostate-specific antigen synthesis and secretion by human placenta: a physiological kallikrein source during pregnancy. , 2000, The Journal of clinical endocrinology and metabolism.

[38]  H. Ito,et al.  Expression and activity of matrix metalloproteinase 2 and 9 in human trophoblasts. , 2003, Placenta.

[39]  Y. Mizutani,et al.  KIT (c-kit oncogene product) pathway is constitutively activated in human testicular germ cell tumors. , 2005, Biochemical and biophysical research communications.

[40]  Dong-Hua Yang,et al.  The relationship between point mutation and abnormal expression of c-fms oncogene in hepatocellular carcinoma. , 2004, Hepatobiliary & pancreatic diseases international : HBPD INT.

[41]  Z. Werb,et al.  Implantation and the placenta: key pieces of the development puzzle. , 1994, Science.

[42]  A. Campana,et al.  A putative role for oncogenes in trophoblast invasion? , 2000, Human reproduction.

[43]  C. Cordon-Cardo,et al.  Expression of granulocyte-macrophage colony-stimulating factor receptors in human prostate cancer. , 1998, Blood.

[44]  D. Green,et al.  The role of Fas ligand in immune privilege , 2001, Nature Reviews Molecular Cell Biology.

[45]  J. Lysiak,et al.  Effects of colony stimulating factor-1 on human extravillous trophoblast growth and invasion. , 1998, The Journal of endocrinology.

[46]  J. Pollheimer,et al.  Signalling pathways regulating the invasive differentiation of human trophoblasts: a review. , 2005, Placenta.

[47]  M. Schaller,et al.  FAK regulates biological processes important for the pathogenesis of cancer , 2003, Cancer and Metastasis Reviews.

[48]  Y. Yoshida Secretion of human chorionic gonadotropin in early pregnancy , 2005, Medical Molecular Morphology.

[49]  K. Pavelić,et al.  Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters. , 2005, Experimental and molecular pathology.

[50]  Reuven Reich,et al.  Thrombin receptor overexpression in malignant and physiological invasion processes , 1998, Nature Medicine.

[51]  M. Merino,et al.  Demonstration of myc and ras oncogene expression by hybridization in situ in hydatidiform mole and in the BeWo choriocarcinoma cell line. , 1986, American journal of obstetrics and gynecology.

[52]  J. Quigley,et al.  The role of urokinase-type plasminogen activator in aggressive tumor cell behavior , 1990, Cancer and Metastasis Reviews.

[53]  P. Chambon,et al.  Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[54]  T. Hurskainen,et al.  Production of Membrane-type Matrix Metalloproteinase-1 (MT-MMP-1) in Early Human Placenta: A Possible Role in Placental Implantation? , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[55]  D. Charnock-Jones,et al.  Localization of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy. , 1996, Human reproduction.

[56]  R. Hynes,et al.  Changes in integrin receptors on oncogenically transformed cells , 1989, Cell.

[57]  T. Siddiqi,et al.  Transforming growth factor-beta 1 expression during placental development. , 1991, American journal of obstetrics and gynecology.

[58]  M. Rees,et al.  Immunohistochemical localization of relaxin, prolactin and prostaglandin synthase in human amnion, chorion and decidua. , 1987, The Journal of endocrinology.

[59]  J. Platt,et al.  Heparanase expression in invasive trophoblasts and acute vascular damage. , 2000, Glycobiology.

[60]  I. Fidler,et al.  The pathogenesis of cancer metastasis , 1980, Nature.

[61]  T. Maruo,et al.  Increase in the Expression of c-erb A and c-erb B mRNAs in the Human Placenta in Early Gestation: Their Roles in Trophoblast Proliferation and Differentiation , 1994 .

[62]  M. Barbacid,et al.  RAS oncogenes: the first 30 years , 2003, Nature Reviews Cancer.

[63]  I. Shih,et al.  Immunohistochemical Localization of Inhibin-α in the Placenta and Gestational Trophoblastic Lesions , 1999 .

[64]  N. Kinukawa,et al.  Immunohistochemical localization of vascular endothelial growth factor in the human placenta. , 1996, Placenta.

[65]  Liotta La Tumor invasion and metastases: role of the basement membrane. Warner-Lambert Parke-Davis Award lecture. , 1984, The American journal of pathology.

[66]  J. Bubeník Tumour MHC class I downregulation and immunotherapy (Review). , 2003, Oncology reports.

[67]  P. Quesenberry,et al.  Coexpression of oncostatin M and its receptors and evidence for STAT3 activation in human ovarian carcinomas. , 2002, Cytokine.

[68]  B. Malassagne,et al.  Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms. , 1992, Cancer research.

[69]  T. Peretz,et al.  Heparanase promotes growth, angiogenesis and survival of primary breast tumors , 2006, International journal of cancer.

[70]  E. Sapi The Role of CSF-1 in Normal Physiology of Mammary Gland and Breast Cancer: An Update , 2004, Experimental biology and medicine.

[71]  A. Aplin,et al.  Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. , 1998, Pharmacological reviews.

[72]  W. Meng,et al.  Expression of some tumor associated factors in human carcinogenesis and development of gastric carcinoma. , 2005, World journal of gastroenterology.

[73]  D. Bostwick,et al.  Expression of opioid peptides in tumors. , 1987, The New England journal of medicine.

[74]  M. Oya,et al.  C-jun activation in acquired cystic kidney disease and renal cell carcinoma. , 2005, The Journal of urology.

[75]  B. Wiedenmann,et al.  Activin A stimulates vascular endothelial growth factor gene transcription in human hepatocellular carcinoma cells. , 2004, Gastroenterology.

[76]  C. Damsky,et al.  Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? , 1997, The Journal of clinical investigation.

[77]  S. Fisher,et al.  Tissue inhibitor of metalloproteinase-3 expression is upregulated during human cytotrophoblast invasion in vitro. , 1997, Developmental genetics.

[78]  I. Sargent,et al.  The Human Placenta , 1993 .

[79]  E DE SALAMANCA,et al.  Pathogenesis of Cancer , 1934, Boletin cultural e informativo - Consejo General de Colegios Medicos de Espana.

[80]  R. Frydman,et al.  Expression of pro-EPIL peptides encoded by the insulin-like 4 (INSL4) gene in chromosomally abnormal pregnancies. , 2000, The Journal of clinical endocrinology and metabolism.

[81]  Arthur T. Hertig THE HUMAN placenta. , 1970, What's new.

[82]  T. Price,et al.  Presence of leptin in breast cell lines and breast tumors. , 1999, Biochemical and biophysical research communications.

[83]  V. Paradis,et al.  Malignant transformation of nontrophoblastic cells is associated with the expression of chorionic gonadotropin beta genes normally transcribed in trophoblastic cells. , 1997, Cancer research.

[84]  Sidney Strickland,et al.  Invasion of the trophoblasts , 1992, Cell.

[85]  P. Leung,et al.  Cellular localization of gonadotropin-releasing hormone (GnRH) I and GnRH II in first-trimester human placenta and decidua. , 2004, The Journal of clinical endocrinology and metabolism.

[86]  J. Bonneterre,et al.  Biological and clinical aspects of prolactin receptors (PRL-R) in human breast cancer , 1990, The Journal of Steroid Biochemistry and Molecular Biology.

[87]  T. Löning,et al.  Expression pattern of the activating protein-1 family of transcription factors in the human placenta. , 2004, Molecular human reproduction.

[88]  L. Gardner,et al.  Expression of the colony stimulating factor-1 receptor (c-fms product) by cells at the human uteroplacental interface. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[89]  L. Claesson‐Welsh,et al.  VEGF receptor signalling ? in control of vascular function , 2006, Nature Reviews Molecular Cell Biology.

[90]  R. Chibbar,et al.  Synthesis of oxytocin in amnion, chorion, and decidua may influence the timing of human parturition. , 1993, The Journal of clinical investigation.

[91]  S. Yagel,et al.  Localization of heparanase in normal and pathological human placenta. , 2002, Molecular human reproduction.

[92]  A. Campana,et al.  Effects of tumour necrosis factor-α, interleukin-1 α, macrophage colony stimulating factor and transforming growth factor β on trophoblastic matrix metalloproteinases , 1999 .

[93]  F. Giancotti,et al.  Elevated levels of the α 5 β 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells , 1990, Cell.

[94]  T. Maruo,et al.  Immunohistochemical localization of epidermal growth factor receptor and myc oncogene product in human placenta: implication for trophoblast proliferation and differentiation. , 1987, American journal of obstetrics and gynecology.

[95]  Catherine A. Mullen Review: Analogies Between Trophoblastic and Malignant Cells , 1998, American journal of reproductive immunology.

[96]  J. Foidart,et al.  Expression of stromelysin-3 in the human placenta and placental bed. , 1997, Placenta.

[97]  S. Kauma,et al.  The differential expression of hepatocyte growth factor and met in human placenta. , 1997, The Journal of clinical endocrinology and metabolism.

[98]  W. Birchmeier,et al.  Met, metastasis, motility and more , 2003, Nature Reviews Molecular Cell Biology.

[99]  W. Parks,et al.  Collagenase-I, stromelysin-I, and matrilysin are expressed within the placenta during multiple stages of human pregnancy. , 1996, Placenta.

[100]  G. Waeber,et al.  Immunolocalization of neuropeptide Y in human pancreatic endocrine tumors , 1995, Peptides.

[101]  G. Schultz,et al.  Regulation of urokinase plasminogen activator production in implanting mouse embryo: effect of embryo interaction with extracellular matrix. , 1996, Biology of reproduction.

[102]  A. Athanassiades,et al.  Vascular endothelial growth factor stimulates proliferation but not migration or invasiveness in human extravillous trophoblast. , 1998, Biology of reproduction.

[103]  I. Laurendeau,et al.  Stimulation of human trophoblast invasion by placental growth hormone. , 2005, Endocrinology.

[104]  J. Strauss,et al.  Thrombin receptors and protease-activated receptor-2 in human placentation: receptor activation mediates extravillous trophoblast invasion in vitro. , 2003, The American journal of pathology.

[105]  H. Lane,et al.  ERBB Receptors and Cancer: The Complexity of Targeted Inhibitors , 2005, Nature Reviews Cancer.

[106]  T. Wahlström,et al.  Corticotrophin-releasing factor in human placenta: localization, concentration and release in vitro. , 1988, Placenta.

[107]  David A. Cheresh,et al.  Role of integrins in cell invasion and migration , 2002, Nature Reviews Cancer.

[108]  G. Viglietto,et al.  Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[109]  F. Petraglia,et al.  Paracrine regulation of endometrial function: interaction between progesterone and corticotropin-releasing factor (CRF) and activin A , 2003, Steroids.

[110]  D. Cheresh,et al.  Involvement of integrin alpha V gene expression in human melanoma tumorigenicity. , 1992, The Journal of clinical investigation.

[111]  F. Petraglia,et al.  Human placenta, chorion, amnion and decidua express different variants of corticotropin-releasing factor receptor messenger RNA. , 2000, Placenta.

[112]  S. Oikawa,et al.  A pregnancy-specific beta 1-glycoprotein, a CEA gene family member, expressed in a human promyelocytic leukemia cell line, HL-60: structures of protein, mRNA and gene. , 1989, Biochemical and biophysical research communications.

[113]  A. Athanassiades,et al.  Role of placenta growth factor (PIGF) in human extravillous trophoblast proliferation, migration and invasiveness. , 1998, Placenta.

[114]  C. Uherek,et al.  CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium , 1995, The Journal of cell biology.

[115]  D. Navot,et al.  Epidermal growth factor and its receptor in human implantation trophoblast: immunohistochemical evidence for autocrine/paracrine function. , 1992, The Journal of clinical endocrinology and metabolism.

[116]  D. Denhardt,et al.  Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. , 1993, Pharmacology & therapeutics.

[117]  P. Sternberg,et al.  FOS-1 Promotes Basement-Membrane Removal during Anchor-Cell Invasion in C. elegans , 2005, Cell.

[118]  C. Duan,et al.  Phosphatidylinositol 3-kinase is required for insulin-like growth factor-I-induced vascular smooth muscle cell proliferation and migration. , 2000, Circulation research.

[119]  E. Sabo,et al.  Epidermal growth factor receptor, c-MET, beta-catenin, and p53 expression as prognostic indicators in stage II colon cancer: a tissue microarray study. , 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.

[120]  A. Mazar,et al.  Characterization of urokinase receptor expression by human placental trophoblasts. , 1992, Blood.

[121]  M. Chen,et al.  Isolation and characterization of PAGE-1 and GAGE-7. New genes expressed in the LNCaP prostate cancer progression model that share homology with melanoma-associated antigens. , 1998, The Journal of biological chemistry.

[122]  S. Luo,et al.  Expression of albumin, IGF-1, IGFBP-3 in tumor tissues and adjacent non-tumor tissues of hepatocellular carcinoma patients with cirrhosis. , 2005, World journal of gastroenterology.

[123]  J. Vieira,et al.  Expression of vascular endothelial growth factor (VEGF) and its receptors in thyroid carcinomas of follicular origin: a potential autocrine loop. , 2005, European journal of endocrinology.

[124]  P. Bischof Endocrine, paracrine and autocrine regulation of trophoblastic metalloproteinases. , 2001, Early pregnancy.

[125]  V. Quaranta,et al.  Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts , 2004, Journal of Cell Science.

[126]  M. Seif,et al.  Cell adhesion molecules on the oocyte and preimplantation human embryo. , 1995, Human reproduction.

[127]  M. Bernaudin,et al.  Expression of erythropoietin and erythropoietin receptor in non-small cell lung carcinomas. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[128]  Staff Ac An introduction to cell migration and invasion. , 2001 .

[129]  F. Petraglia,et al.  Identification of immunoreactive neuropeptide-gamma in human placenta: localization, secretion, and binding sites. , 1989, Endocrinology.

[130]  G. Emons,et al.  Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer , 2003, Reproductive biology and endocrinology : RB&E.

[131]  M. Cohen,et al.  Metalloproteinases and human placental invasiveness. , 2006, Placenta.

[132]  S. Chauhan,et al.  Differential activity of cathepsin L in human placenta at two different stages of gestation. , 2002, Placenta.

[133]  R. Bajoria,et al.  Ontogeny of endogenous secretion of immunoreactive-thyrotropin releasing hormone by the human placenta. , 1998, The Journal of clinical endocrinology and metabolism.

[134]  G. Krikun,et al.  Implications of Decidualization-Associated Protease Expression in Implantation and Menstruation , 1999, Seminars in reproductive endocrinology.

[135]  W. Vale,et al.  Expression of CRF1 and CRF2 receptors in human cancers. , 2003, The Journal of clinical endocrinology and metabolism.

[136]  Sohaib A. Khan,et al.  Transforming growth factor-β1 expression during placental development , 1991 .

[137]  I. Martins,et al.  [Prognosis value of p53, C-erB-2 and Ki67 proteins in ovarian carcinoma]. , 2001, Acta medica portuguesa.

[138]  Yukio Nakamura,et al.  Small guanosine triphospatase RhoA and Rho-associated kinase as regulators of trophoblast migration. , 2002, The Journal of clinical endocrinology and metabolism.

[139]  K. Lim,et al.  Integrin switching regulates normal trophoblast invasion. , 1994, Development.

[140]  Judith E. Cartwright,et al.  Hepatocyte growth factor induced human trophoblast motility involves phosphatidylinositol-3-kinase, mitogen-activated protein kinase, and inducible nitric oxide synthase. , 2002, Experimental cell research.

[141]  J. O'Connell,et al.  The Fas signalling pathway and its role in the pathogenesis of cancer. , 2004, Current opinion in pharmacology.

[142]  R. Akhurst,et al.  Chorionic gonadotrophin-beta mRNA, a trophoblast marker, is expressed in human 8-cell embryos derived from tripronucleate zygotes. , 1988, Human reproduction.

[143]  J. Ryan,et al.  The expression of stem cell factor and its receptor, c-kit in human endometrium and placental tissues during pregnancy. , 1996, The Journal of clinical endocrinology and metabolism.

[144]  H. Cantiello,et al.  Trophoblast signalling: knowns and unknowns--a workshop report. , 2005, Placenta.

[145]  H. Matsuo,et al.  Role of epidermal growth factor (EGF) and its receptor in the development of the human placenta. , 1995, Reproduction, fertility, and development.

[146]  R. Berkowitz,et al.  c-myc, c-erbB-2, c-fms and bcl-2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma. , 1998, The Journal of reproductive medicine.

[147]  B. Ponder,et al.  Molecular Genetics of Cancer , 1992, Nature Medicine.

[148]  S. Yagel,et al.  Developmental regulation of the expression of 72 and 92 kd type IV collagenases in human trophoblasts: a possible mechanism for control of trophoblast invasion. , 1994, American journal of obstetrics and gynecology.

[149]  Y. Itoh,et al.  Preferential Inactivation of Tissue Inhibitor of Metalloproteinases-1 That Is Bound to the Precursor of Matrix Metalloproteinase 9 (Progelatinase B) by Human Neutrophil Elastase (*) , 1995, The Journal of Biological Chemistry.

[150]  D. Chianese,et al.  A specific antibody to a new peptide growth factor from human placenta: immunocytochemical studies on its location and biosynthesis. , 1986, Biochemistry.

[151]  S. J. Kim,et al.  Expression and amplification of cellular oncogenes in human developing placenta and neoplastic trophoblastic tissue. , 2010, Asia-Oceania journal of obstetrics and gynaecology.

[152]  R. Ueda,et al.  Altered regulation of c-jun and its involvement in anchorage-independent growth of human lung cancers , 2006, Oncogene.

[153]  R. Kramer,et al.  Degradation of extracellular matrix by the trophoblastic cells of first‐trimester human placentas , 1985, Journal of cellular biochemistry.

[154]  I. McCutcheon,et al.  The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. , 2000, Endocrine reviews.

[155]  J. Iwamoto,et al.  Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori , 2005, Scandinavian journal of gastroenterology.

[156]  P. Ratcliffe,et al.  Regulation of angiogenesis by hypoxia: role of the HIF system , 2003, Nature Medicine.

[157]  Alfonso Bellacosa,et al.  The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. , 2003, Cancer research.

[158]  T. Rebbeck,et al.  Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma , 2002, Cancer.

[159]  M. Oldenburg,et al.  The neural cell adhesion molecule NCAM in multiple myeloma. , 1996, Leukemia & lymphoma.

[160]  C. Damsky,et al.  Plasma membrane-associated pY397FAK is a marker of cytotrophoblast invasion in vivo and in vitro. , 2001, The American journal of pathology.

[161]  Robert A. Goulart,et al.  Expression of c-kit in adenoid cystic carcinoma of the breast. , 2005, American journal of clinical pathology.

[162]  R. Berkowitz,et al.  Osteopontin as a potential diagnostic biomarker for ovarian cancer. , 2002, JAMA.

[163]  D. Montell Anchors Away! Fos Fosters Anchor-Cell Invasion , 2005, Cell.

[164]  S. Bellone,et al.  High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer. , 2005, Gynecologic oncology.

[165]  S. Lye,et al.  Activin is a local regulator of human cytotrophoblast cell differentiation. , 1997, Endocrinology.

[166]  H. Varmus,et al.  Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[167]  F. Petraglia,et al.  Expression of urocortin mRNA and peptide in the human prostate and in prostatic adenocarcinoma , 2002, The Prostate.

[168]  B. Vandenbunder,et al.  Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway , 2002, Oncogene.

[169]  Wei Wu,et al.  Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma. , 2005, World journal of gastroenterology.

[170]  R. Nakano,et al.  Production of inhibin A and inhibin B in human ovarian sex cord stromal tumors. , 1997, American journal of obstetrics and gynecology.

[171]  H. Kliman,et al.  Biosynthesis and turnover of a 34-kDa protein growth factor in human cytotrophoblasts. , 1988, European journal of biochemistry.

[172]  E. Domany,et al.  Human cancers overexpress genes that are specific to a variety of normal human tissues. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[173]  J. Blenis,et al.  Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression , 2004, Oncogene.

[174]  M. Kasuga,et al.  Gastric Epithelial Cells Secrete A PDGF-like Peptide, a Potent Mitogen for Human Gastric Fibroblasts , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[175]  L. Sunde,et al.  Localization and significance of urokinase plasminogen activator and its receptor in placental tissue from intrauterine, ectopic and molar pregnancies. , 1999, Placenta.

[176]  E. Lee,et al.  The melanoma antigen gene as a surveillance marker for the detection of circulating tumor cells in patients with breast carcinoma , 2005, Cancer.

[177]  T. Löning,et al.  Expression Pattern of the Adhesion Molecule CEACAM1 (C-CAM, CD66a, BGP) in Gestational Trophoblastic Lesions , 2001, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[178]  P. Jubinsky,et al.  Demonstration of the low affinity α subunit of the granulocyte-macrophage colony-stimulating factor receptor (GM-CSF-Rα) on human trophoblast and uterine cells , 1994 .

[179]  B. Malassagne,et al.  Free Human Chorionic Gonadotropin β Subunit in Gonadal and Nongonadal Neoplasms , 1992 .

[180]  J. Sinkovics,et al.  Human natural killer cells: a comprehensive review. , 2005, International journal of oncology.

[181]  L. Liotta,et al.  Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm3-transfected melanoma cells , 1991, Cell.

[182]  Brian L Hood,et al.  Proteomic Analysis of Formalin-fixed Prostate Cancer Tissue*S , 2005, Molecular & Cellular Proteomics.

[183]  G. Kundu,et al.  Osteopontin Induces AP-1-mediated Secretion of Urokinase-type Plasminogen Activator through c-Src-dependent Epidermal Growth Factor Receptor Transactivation in Breast Cancer Cells* , 2004, Journal of Biological Chemistry.

[184]  K. Conrad,et al.  Expression of the erythropoietin receptor by trophoblast cellsin the human placenta. , 1999, Biology of reproduction.

[185]  D. Mcfadden,et al.  Leptin is a growth factor in cancer. , 2004, The Journal of surgical research.

[186]  M. Ricote,et al.  IL‐6, its receptors and its relationship with bcl‐2 and bax proteins in infiltrating and in situ human breast carcinoma , 2005, Histopathology.

[187]  K. Fujikawa,et al.  The Ets‐1 and Ets‐2 transcription factors activate the promoters for invasion‐associated urokinase and collagenase genes in response to epidermal growth factor , 1998, International journal of cancer.

[188]  M. Hulett,et al.  Heparanase: a key enzyme involved in cell invasion. , 2001, Biochimica et biophysica acta.

[189]  L. Lund,et al.  Messenger RNA for membrane-type 2 matrix metalloproteinase, MT2-MMP, is expressed in human placenta of first trimester. , 2000, Placenta.

[190]  T. Nakano,et al.  Correlation of cervical carcinoma c‐erb B‐2 oncogene with cell proliferation parameters in patients treated with radiation therapy for cervical carcinoma , 1997, Cancer.

[191]  P. Seeburg,et al.  Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells , 1984, Nature.

[192]  N. Umesaki,et al.  Production of activin A in hyperplasia and adenocarcinoma of the human endometrium. , 2001, Gynecologic oncology.

[193]  E. Dejana,et al.  Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? , 1997, The Journal of clinical investigation.

[194]  T. Taguchi,et al.  Urokinase type plasminogen activator receptor is a novel prognostic factor in breast cancer. , 1997, Anticancer research.

[195]  S. Barnwell,et al.  Occurrence of methionine enkephalin in human placental villus. , 1980, Biochemical pharmacology.

[196]  A. Agarwal,et al.  PAR1 Is a Matrix Metalloprotease-1 Receptor that Promotes Invasion and Tumorigenesis of Breast Cancer Cells , 2005, Cell.

[197]  O. Pappo,et al.  Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis , 1999, Nature Medicine.

[198]  R. Frydman,et al.  Identification of pro-EPIL and EPIL peptides translated from insulin-like 4 (INSL4) mRNA in human placenta. , 1997, The Journal of clinical endocrinology and metabolism.

[199]  N. Ahn,et al.  Signal transduction through MAP kinase cascades. , 1998, Advances in cancer research.

[200]  Wenjun Guo,et al.  Integrin signalling during tumour progression , 2004, Nature Reviews Molecular Cell Biology.

[201]  Jean-Philippe Brunet,et al.  The melanocyte differentiation program predisposes to metastasis after neoplastic transformation , 2005, Nature Genetics.

[202]  W. B. Watkins,et al.  Somatostatin in cytotrophoblast of the immature human placenta: localization by immunoperoxidase cytochemistry. , 1980, The Journal of clinical endocrinology and metabolism.

[203]  O. Topolcan,et al.  Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples. , 2005, Anticancer research.

[204]  R. Ohlsson,et al.  Spatial and temporal pattern of cellular myc oncogene expression in developing human placenta: Implications for embryonic cell proliferation , 1984, Cell.

[205]  M. Sixt,et al.  EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor. , 2006, Gynecologic oncology.

[206]  D. Matesic,et al.  Identification of a 34,000-dalton mitogenic protein associated with plasma membranes from human A431 epidermoid carcinoma cells. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[207]  C. Heldin,et al.  Coexpression of the sis and myc proto-oncogenes in developing human placenta suggests autocrine control of trophoblast growth , 1985, Cell.

[208]  G. Nolan,et al.  Mapping normal and cancer cell signalling networks: towards single-cell proteomics , 2006, Nature Reviews Cancer.

[209]  M. Stearns,et al.  Specific transcription factors prognostic for prostate cancer progression. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[210]  D. Torry,et al.  Placenta Growth Factor: Potential Role in Pregnancy , 1999, American journal of reproductive immunology.

[211]  I. Shih,et al.  The Role of E-cadherin in the Motility and Invasion of Implantation Site Intermediate Trophoblast. , 2002, Placenta.

[212]  K. Stefanaki,et al.  Enhanced mRNA expression of tissue inhibitor of metalloproteinase‐1 (TIMP‐1) in breast carcinomas is correlated with adverse prognosis , 2002, The Journal of pathology.

[213]  S. Hankinson,et al.  Insulin-like growth factors and neoplasia , 2004, Nature Reviews Cancer.

[214]  G. Emons,et al.  Biology of the gonadotropin-releasing hormone system in gynecological cancers. , 2002, European journal of endocrinology.

[215]  Albino Martins,et al.  Overexpression of platelet-derived growth factor receptor α in breast cancer is associated with tumour progression , 2005, Breast Cancer Research.

[216]  M. Neumaier,et al.  The human tumor suppressor CEACAM1 modulates apoptosis and is implicated in early colorectal tumorigenesis , 2004, Oncogene.

[217]  M. West,et al.  Gene expression predictors of breast cancer outcomes , 2003, The Lancet.

[218]  C. Redman,et al.  Gestational regulation of granulocyte-colony stimulating factor receptor expression in the human placenta. , 1999, Biology of reproduction.

[219]  M. Haynes,et al.  Cytokine production in first trimester chorionic villi: detection of mRNAs and protein products in situ. , 1993, Cellular immunology.

[220]  L. Tyrey Human chorionic gonadotropin: structural, biologic, and immunologic aspects. , 1982, Seminars in oncology.

[221]  K. Conrad,et al.  Expression of erythropoietin by the human placenta. , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[222]  A. Campana,et al.  Effects of tumour necrosis factor-alpha, interleukin-1 alpha, macrophage colony stimulating factor and transforming growth factor beta on trophoblastic matrix metalloproteinases. , 1999, Molecular human reproduction.

[223]  A. Kennedy Chorionic tumours. , 1997, Journal of women's health.

[224]  F. Schmitz,et al.  Expression of functional prolactin and its receptor in human colorectal cancer , 2002, International Journal of Colorectal Disease.

[225]  K. von Figura,et al.  Partial purification and characterization of heparan sulfate specific endoglucuronidase. , 1976, Biochemical and biophysical research communications.

[226]  V. Praloran,et al.  Plasminogen- and colony-stimulating factor-1-associated markers in bladder carcinoma: diagnostic value of urokinase plasminogen activator receptor and plasminogen activator inhibitor type-2 using immunocytochemical analysis , 2002, Urological Research.

[227]  M. Scippo,et al.  Syncytiotrophoblastic localization of the human growth hormone variant mRNA in the placenta , 1993, Molecular and Cellular Endocrinology.

[228]  K. Leslie,et al.  Linkage of two human pregnancy-specific beta 1-glycoprotein genes: one is associated with hydatidiform mole. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[229]  T. Peretz,et al.  Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis. , 2000, The American journal of pathology.

[230]  D. Rushton,et al.  Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta. , 1995, Growth factors.

[231]  L. David,et al.  c-erb B-2 Expression Is Associated with Tumor Location and Venous Invasion and Influences Survival of Patients with Gastric Carcinoma , 2002, International journal of surgical pathology.

[232]  D. Maglione Persico MG.Isolation of a human placenta cDNA coding for a potein related to the vascular premeability factor , 1991 .

[233]  G. Viglietto,et al.  Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14. , 1993, Oncogene.

[234]  J. Pollard,et al.  The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[235]  C. Damsky,et al.  Trophoblast pseudo-vasculogenesis: faking it with endothelial adhesion receptors. , 1998, Current opinion in cell biology.

[236]  B. Tsang,et al.  Both mitogen-activated protein kinase and phosphatidylinositol 3-kinase signalling are required in epidermal growth factor-induced human trophoblast migration. , 2004, Molecular human reproduction.

[237]  C. Nappi,et al.  Peptide signaling in human placenta and membranes: autocrine, paracrine, and endocrine mechanisms. , 1996, Endocrine reviews.

[238]  W. Birchmeier,et al.  E-cadherin as a tumor (invasion) suppressor gene. , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[239]  H. Kato,et al.  Significance of expression of TGF-beta in pulmonary metastasis in non-small cell lung cancer tissues. , 2003, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[240]  E. Ruoslahti,et al.  Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. , 1990, Cell.

[241]  K. Matsumoto,et al.  Hepatocyte growth factor promotes the growth of cytotrophoblasts by the paracrine mechanism. , 1995, Journal of biochemistry.

[242]  M. Shibuya,et al.  Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. , 1994, The Journal of biological chemistry.

[243]  P. Bischof,et al.  Leptin modulates extracellular matrix molecules and metalloproteinases: possible implications for trophoblast invasion. , 2000, Molecular human reproduction.

[244]  E. Sabo,et al.  Epidermal Growth Factor Receptor, c-MET, β-Catenin, and p53 Expression as Prognostic Indicators in Stage II Colon Cancer , 2004, Clinical Cancer Research.

[245]  G. Watkins,et al.  KiSS-1 Expression in Human Breast Cancer , 2005, Clinical & Experimental Metastasis.

[246]  A. Ullrich,et al.  The discovery of receptor tyrosine kinases: targets for cancer therapy , 2004, Nature Reviews Cancer.

[247]  R. Ohlsson,et al.  Insulin‐like growth factor 2 and short‐range stimulatory loops in control of human placental growth. , 1989, The EMBO journal.

[248]  山下 和哉 Production of inhibin A and inhibin B in human ovarian sex cord stromal tumors , 1999 .

[249]  D. Rifkin,et al.  Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade , 1986, Cell.

[250]  G. Waeber,et al.  Immunolocalization of neuropeptide Y in human pituitary tumours , 1998, Regulatory Peptides.

[251]  E. Gonzalez,et al.  Immunochemical localization of platelet-derived growth factor in placenta and its possible role in pre-eclampsia. , 1999, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[252]  J. Downward Targeting RAS signalling pathways in cancer therapy , 2003, Nature Reviews Cancer.

[253]  Judith P. Johnson Cell adhesion molecules of the immunoglobulin supergene family and their role in malignant transformation and progression to metastatic disease , 1991, Cancer and Metastasis Reviews.

[254]  J. Foidart,et al.  Membrane-type matrix metalloproteinase-1 expression at the site of human placentation. , 1996, Placenta.

[255]  C. Redman,et al.  Cytotrophoblasts: Masters of disguise , 1997, Nature Medicine.

[256]  M. Takeichi,et al.  Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. , 1993, Cancer research.

[257]  A. Pinchera,et al.  Insulin-Like Growth Factor II (IGF-II) Immunohistochemistry in Breast Cancer: Relationship with the Most Important Morphological and Biochemical Prognostic Parameters , 2002, The International journal of biological markers.

[258]  Wenmei Li,et al.  Matrix metalloproteinase 11 depletion inhibits cell proliferation in gastric cancer cells. , 2005, Biochemical and biophysical research communications.

[259]  U. Murthy,et al.  A new trophoblast-derived growth factor from human placenta: purification and receptor identification. , 1986, Biochemistry.

[260]  P. Jubinsky,et al.  Demonstration of the low affinity alpha subunit of the granulocyte-macrophage colony-stimulating factor receptor (GM-CSF-R alpha) on human trophoblast and uterine cells. , 1994, Journal of reproductive immunology.

[261]  J. Nesland,et al.  Neuroendocrine differentiation in breast lesions. , 1988, Pathology, research and practice.

[262]  C. Van Waes,et al.  Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF‐κB and AP‐1 activation and IL‐8 and VEGF expression in human head and neck squamous cell carcinoma lines , 2002, International journal of cancer.

[263]  A J Owen,et al.  Detection of c-sis transcripts and synthesis of PDGF-like proteins by human osteosarcoma cells. , 1984, Science.

[264]  D. Charnock-Jones,et al.  Localization of leukemia inhibitory factor and its receptor in human placenta throughout pregnancy. , 1999, Biology of reproduction.

[265]  R. Smith,et al.  Localization and characterization of urocortin during human pregnancy. , 2000, Placenta.

[266]  T. Maruo,et al.  Cytologic localization of epidermal growth factor and its receptor in developing human placenta varies over the course of pregnancy. , 1991, American journal of obstetrics and gynecology.

[267]  S. Hsu,et al.  Differential expression of vascular endothelial growth factor, placenta growth factor and their receptors in placentae from pregnancies complicated by placenta accreta. , 2006, Placenta.

[268]  A. Hall,et al.  Rho GTPases and the actin cytoskeleton. , 1998, Science.

[269]  N. Ferrara,et al.  Differential Transcriptional Regulation of the Two Vascular Endothelial Growth Factor Receptor Genes , 1997, The Journal of Biological Chemistry.

[270]  C. Sawyers,et al.  The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.

[271]  S. K. Boey,et al.  Plasma Membrane , 2005 .

[272]  I. Pecker,et al.  The FASEB Journal express article 10.1096/fj.00-0895fje. Published online May 29, 2001. , 2022 .

[273]  D. Egan,et al.  Human placental chorionic renin: production, purification and characterization. , 1988, Biochimica et biophysica acta.

[274]  J. Wands,et al.  Physiological studies of human chorionic gonadotropin and free subunits in the amniotic fluid compartment compared to those in maternal serum. , 1988, The Journal of clinical endocrinology and metabolism.

[275]  R. Pollack,et al.  Cancer biology. , 1978, Science.

[276]  S. Dixon,et al.  Noncatalytic domain of uPA stimulates human extravillous trophoblast migration by using phospholipase C, phosphatidylinositol 3-kinase and mitogen-activated protein kinase. , 2003, Experimental cell research.

[277]  M. S. Ahmed,et al.  Properties and functions of human placental opioid system. , 1992, Life sciences.

[278]  M. Volm,et al.  Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas , 2005, Journal of Cancer Research and Clinical Oncology.

[279]  T. Nikaido,et al.  Expression and activation of MAP kinases, ERK1/2, in the human villous trophoblasts. , 2003, Placenta.

[280]  W. Hahn,et al.  Modelling the molecular circuitry of cancer , 2002, Nature Reviews Cancer.

[281]  M. Plebani,et al.  Neural cell adhesion molecule (N-CAM) in gastrointestinal neoplasias. , 1997, Anticancer research.

[282]  Kathryn A. O’Donnell,et al.  The great MYC escape in tumorigenesis. , 2005, Cancer cell.

[283]  D. I. Lewis-Jones,et al.  Oncogene and tumour suppressor gene products during trophoblast differentiation in the first trimester. , 1998, Molecular human reproduction.

[284]  M. Roncalli,et al.  C-myc and tumour suppressor gene product expression in developing and term human trophoblast. , 1994, Placenta.

[285]  Z. Werb,et al.  92-kD type IV collagenase mediates invasion of human cytotrophoblasts , 1991, The Journal of cell biology.

[286]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[287]  B. Huppertz,et al.  Immunohistochemistry of matrix metalloproteinases (MMP), their substrates, and their inhibitors (TIMP) during trophoblast invasion in the human placenta , 1997, Cell and Tissue Research.

[288]  O. Nishimura,et al.  Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor , 2001, Nature.

[289]  L. Tashima,et al.  Human relaxins in normal, benign and neoplastic breast tissue. , 1994, Journal of molecular endocrinology.

[290]  T. Hei,et al.  Ionizing radiation induces alterations in cellular proliferation and c-myc, c-jun and c-fos protein expression in breast epithelial cells. , 2004, International journal of oncology.

[291]  A. Staff An introduction to cell migration and invasion , 2001, Scandinavian journal of clinical and laboratory investigation.

[292]  Alfonso Bellacosa,et al.  Epithelial–mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways , 2005, Oncogene.

[293]  T. Irimura,et al.  Heparanases and tumor metastasis , 1988, Journal of cellular biochemistry.

[294]  A. Toker,et al.  Akt signaling and cancer: surviving but not moving on. , 2006, Cancer research.

[295]  Hong-Jin Kim,et al.  Modulation of E-Cadherin by Hepatocyte Growth Factor Induces Aggressiveness of Gastric Carcinoma , 2005, Annals of surgery.

[296]  J. Mössner,et al.  Predictive Value of Heparanase Expression in the Palliative Therapy of Pancreatic Cancer , 2005, Pancreatology.

[297]  Oliver Hantschel,et al.  Regulation of the c-Abl and Bcr–Abl tyrosine kinases , 2004, Nature Reviews Molecular Cell Biology.

[298]  D. Navot,et al.  Immunohistochemical localization of transforming growth factor-alpha in human endometrium, decidua, and trophoblast. , 1993, The Journal of clinical endocrinology and metabolism.

[299]  M. Blankenstein,et al.  Expression of the gene encoding growth hormone in the human mammary gland. , 1995, The Journal of clinical endocrinology and metabolism.

[300]  R. Baxter,et al.  The IGF axis and programmed cell death , 1999, Immunology and cell biology.

[301]  P. Lala,et al.  Regulation of human trophoblast migration and invasiveness. , 2002, Canadian journal of physiology and pharmacology.

[302]  J. Lotem,et al.  Control of apoptosis in hematopoiesis and leukemia by cytokines, tumor suppressor and oncogenes. , 1996, Leukemia.

[303]  K. Salminen,et al.  Localization and ceoncentration of - and -lipotrophin in human placenta , 1987 .